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Abstract
Female B10.S mice are highly resistant to proteolipid protein (PLP) 139–151-induced experimental autoimmune encephalomyelitis (EAE) and depletion of PLP 139–151- reactive CD4+CD25+regulatory T (Treg) cells can slightly increase their EAE susceptibility. Although male B10.S mice are moderately susceptible to EAE, we report that depletion of Treg cells in male B10.S mice before
immunization with PLP 139–151 renders them highly susceptible to severe EAE with more CNS neutrophil infiltrates than nondepleted controls. Increased susceptibility is associated with an enhanced PLP 139–151-specific T cell response and greater production of IFN-γ, IL-6, and IL-17. Male CD4+CD25+ effector cells depleted of Treg cells proliferate to a greater degree than those from
females in response to either anti-CD3 or PLP 139–151. These data suggest that because of their capacity to regulate potent autoaggressive effector cells, Treg cells partly contribute to the resistance to autoimmunity in the male mice.
Abbreviations: EAE, experimental autoimmune encephalomyelitis; Treg, regulatory T; PLP, proteolipid protein; wt, wild type;
tg, transgenic; TMEV, Theiler’s murine encephalomyelitis virus; 7-AAD, 7-aminoactinomycin D; PMN, polymorphonuclear
leukocyte

Autoimmune diseases are more prevalent in females than in
males. This disparity also exists in autoimmune disease models (1)
and appears to be partly hormone dependent. Sex steroids ameliorate experimental autoimmune encephalomyelitis (EAE)3, an animal model of multiple sclerosis (2– 4), but the mechanism(s) by
which they alter the disease are unclear. Because immune cells express estrogen and androgen receptors (5, 6), sex hormones may act
directly on Ag-specific T cells to alter their functions. Some studies
suggest that sex steroids induce immune deviation from a Th1 to a
Th2 phenotype (2– 4, 7).
A subset of CD4+ cells called CD4+CD25+ regulatory T (Treg)
cells that expresses Forkhead box P3 (Fox P3) can control autoimmune responses (8 –10). Estrogen modulates the expression of
Fox P3 mRNA and middle-aged male mice with EAE have diminished Treg cell activity (11, 12), but it is not known whether
Treg cell functions are affected by gender. Immunization with
myelin proteolipid protein (PLP) 139– 151 results in EAE in male
and female SJL (I-As) mice with comparable severity, but only
female mice show chronic relapsing- remitting disease (13, 14).
In contrast, B10.S mice (H-25 congenic with SJL) are relatively
resistant to PLP 139–151-induced EAE (15), but it is not known
whether gender affects resistance. Using IAs tetramers for PLP
139–151, we found more myelin PLP-specific Treg cells in the naive periphery of female B10.S mice than in SJL mice (15). Depletion of Treg cells in vivo in female B10.S mice predisposed them
moderately to EAE.

We report here that although male B10.S mice have fewer PLP
139–151 tetramer+ CD4 cells than female mice, depletion of Treg
cells in vivo makes them more susceptible to PLP 139–151-induced EAE with increased inflammatory cytokine production and
more severe clinical and histological disease than nondepleted
mice. Although male and female B10.S mice have comparable
Treg cell functions, effector cells expand more in male than in female mice in response to TCR-mediated stimulation. These results
indicate that Treg cells partly contribute to gender differences in
EAE susceptibility.
Materials and Methods
Mice
B10.S (B10.S-H2s/Sg) wild-type (wt) mice 4–8 wk old were
obtained from McLaughlin Research Institute. B10.S/SgTg(TcrPLP)1858Hpw mice (referred to as 5B6 transgenic (tg) B10.S
mice) transgenic for the PLP139–151- specific TCR 5B6 were generated
and maintained as described previously (16).
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Peptide synthesis and immunization procedures
PLP 139–151 (HSLGKWLGHPDKF) and neuraminidase (NASE)
101–120 (EALVRQGLAKVAYVYKPNNT) were synthesized on
Fmoc chemistry and used for immunizations as described previously (15).

0
1.2 ± 0.6
0/8 (0)
3/9 (33.3)

0
15.0 ± 4.6
Females
Rat IgG control
Anti-CD25

a. Numbers are mean ± SEM.
b. B10.S male or female mice were treated with anti-CD25 or rat IgG Ab on days 5 and 3 prior to immunization with PLP 139–151 in CFA, and the disease was scored as described in
Materials and Methods and compared between groups.
c. Represents only mice that showed clinical disease. PMN score: 3+, solid, abscess-like foci with mostly neutrophils; 2+, multiple foci with mixtures of neutrophils and mononuclear
cells; 1+, few neutrophils; 0, no neutrophils but when inflammatory foci were present, the infiltrates were predominantly mononuclear cells.

1.6 ± 1.1
23.8 ± 15.4

3.9 ± 2.3
44.8 ± 27.7

0
1/9 (11.1)

0
0

0
1/9 (11.1)

8/8 (100)
7/9 (77.8)

Immunology 175 (2005)

2.3 ± 1.2
21.0 ± 12.4

10/12 (83.3)
4/14 (28.6)
0
2/12 (16.6)
6/14 (42.8)
2/14 (14.3)
0.0004
18.6 ± 9.4
0
124.9 ± 23.2
2/14 (14.3)
0.0003 		
8.3 ± 5.6
60.6 ± 12.6
0.0008
10.3 ± 4.1
64.3 ± 11.8
0.0002

1+
2+
Mean day
of onsetc

Mean maximum score

Meninges

Parenchyma

Total

3+

PMN (neutrophil) score (%)

of

0.25 ± 0.1
1.8 ± 0.4
0.001

Statistics
Student’s t test was used to determine significance of data except
for rank correlations between inflammatory foci and PMN scores,
which were determined by Wilcoxon signed rank test. A value of p ≤
0.05 was considered significant.

Treatment
Incidence (%)
		

Histopathology
Following induction of EAE, the mice were monitored for clinical signs of disease for 4 wk and scored as described previously (13).
Mice were killed when their score reached ≥4 or when they began to
recover. Brains and spinal cords were fixed in 10% phosphate-buffered formalin. Histologic disease was evaluated as previously described (13) and polymorphonuclear leukocyte (PMN) infiltration as
described in Table I legend.

Clinical

Real-time (TaqMan) RT-PCR
Total RNA was extracted from CD4+CD25- and CD4+CD2+ cells
from a group of B10.S mice followed by treatment with DNase 1
(RNeasy kit; Qiagen). cDNA was synthesized using TaqMan RT reagents (Applied Biosystems). Fox P3 and GAPDH mRNA was measured by PCR in separate tubes in duplicates using probes labeled
with FAM and VIC and with TAMRA as a quencher using TaqMan
universal mix and the ABI Prism 7700 sequence detection system (Applied Biosystems). Primers and probe for GAPDH were purchased
(Applied Biosystems). Fox P3 sequences were as described previously (17). A comparative threshold cycle (CT) was used to determine
mRNA expression of Fox P3 and GAPDH relative to no-template control (calibrator). CT value was normalized for each sample using the
formula: ΔCT = CT (Fox P3) - CT (GAPDH), and the relative expression of
Fox P3 was then calculated using the formula 2-CT.

Table I. Clinical and histologic EAE in B10.S mice treated with anti-CD25 or control Ab a

IAs tetramer staining
Frequencies of Ag-specific T cells were determined by flow cytometry using IAs/PLP 139–151 and Theiler’s murine encephalomyelitis
virus (TMEV) 70–86 tetramers (negative control) as described previously (15). Four-color analysis included anti-CD25/FITC (clone, 7D4),
IAs tetramers (PE), 7-aminoactinomycinD( 7-AAD), and anti-CD4-allophycocyanin (clone, RM4-5). Percentages of tetramer+ cells in the live
(7-AAD-) CD4+population were determined.

		

Histopathology (mean ± SEM) (No. of Inflammatory Lesions)

Flow cytometry
To study cellular subsets in lymph nodes, various mAbs procured
from BD Pharmingen. After staining, cells were analyzed by flow cytometry (FACSCalibur; BD Biosciences); data were analyzed using
FlowJo software (Tree Star).

Cytokine analysis
CD3+ T cells were enriched from anti-CD25- and control Ig-treated
B10.S mice 10 days after immunization with PLP 139–151. They were
stimulated with APCs loaded with PLP 139–151 (50 μg/ml) for 4–6
days. Supernatants on day 2 were tested for cytokines by ELISAs, and
frequencies of cytokinesecreting cells were determined on day 4 by intracellular staining, as described previously (15).
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Proliferation assays
To assess inhibitory effects of Treg cells, PLP 139–151-specific 5B6
tg T cells were fractionated into CD4+CD25+ and CD4+CD25- cells by
magnetic separation (Miltenyi Biotec). They were plated at a density
of 1 x 106 cells/ml in the presence of APCs and PLP 139–151 (20 μg/
ml) for 2 days in complete DMEM. After pulsing with 1 mCi of [3H]
thymidine (1 Ci = 37 GBq) for 16 h, proliferation was measured as
counts per minute. CD3+ T cells enriched by negative selection (R&D
Systems) from immunized B10.S wt mice were stimulated with PLP
139–151 in the presence of APCs. Response of CD4+CD25- T cells to
anti-CD3 (1 μg/ml, clone, 145-2C11; BD Pharmingen) was tested with
CD11c+ cells as APCs.

et al. in

Males
Rat IgG control
3/12 (25)
14.3 ± 1.9
Anti-CD25
12/14 (85.7)
17.3 ± 1.3
p values 			
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Figure 1. Effect of anti-CD25 treatment on CNS inflammatory infiltrates in PLP 139–151-immunized male and female B10.S mice. a, An
inflammatory focus in an anti-CD25-treated male mouse with EAE
contains a predominance of neutrophils intermixed with mononuclear cells (PMN score = 3+; see legend to Table I). b, Typical mononuclear infiltrates in an anti-CD25- treated female mouse (PMN score =
0). c, A small subpial mononuclear cell infiltrate in a control Ig-treated
male mouse. d, No inflammatory cell infiltrates in a control Ig-treated
female mouse. Each panel is from the spinal cord with a spinal nerve
root on the left side of the field. Luxol fast blue-H&E stain. Original
magnification, ×240. Bar in a = 25 μm.
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Figure 2. PLP 139–151-specific
Treg cells are functional in both
male and female B10.S mice. a,
Fox P3 and GAPDH mRNA expression in Treg and CD4+CD25cells. Each bar represents relative Fox P3 mRNA mean ±
SEM values. n =5 (four to five
mice per sample). b, Treg and
CD4+CD25- cells isolated from
PLP 139–151-specific tg B10.S
mice of either sex were stimulated with PLP 139–151 together
at indicated ratios or separately
and proliferation was measured
as described in Materials and
Methods. A representative experiment is shown.

Table II. Lymphocyte subsets in male and female B10.S micea
Marker
CD3b

Gate: CD3+ cells
CD4
CD8
CD25c
Gate: CD3- cells
CD11b
CD11c
B220

Male

Female

51.06 ± 0.99

44.68 ± 1.84

49.36 ± 0.77
42.82 ± 0.43
7.70 ± 0.26

50.52 ± 1.33
40.52 ± 1.43
9.71 ± 0.29

3.77 ± 0.55
0.97 ± 0.08
77.98 ± 1.50

3.23 ± 0.26
0.97 ± 0.05
80.6 ± 0.61

a. Lymph node cells from male and female B10.S mice were stained
with the indicated markers. The percentages of individual subsets
were then determined by flow cytometry. n = 5/group
b. p ≤ 0.007
c. p ≤ 0.00047

Results and Discussion
We report here that Treg cells partly contribute to gender differences in susceptibility to EAE. We previously showed that PLP
139–151-reactive Treg cells exist in the naive periphery of EAE-resistant B10.S female mice and that depletion of these in vivo before
immunization with PLP 139–151 resulted in expansion of IFN-γproducing cells and induction of EAE in ~30% of mice (15). Because
autoimmune diseases are more common in females than males, we
hypothesized that there may be gender differences in the function
of the naturally occurring CD4+CD25+ Treg cell subset.
When we depleted Treg cells in vivo by administration of
anti- CD25 Ab in male B10.S mice before immunization, 85% of
the mice (12 of 14) developed moderate to severe EAE, whereas
only 3 of 12 control mice (25%) developed mild EAE, i.e., loss of
tail tonicity (p ≤ 0.001) (Table I). In agreement with our previous
results (15), a small number of female B10.S mice (three of nine,
33%) depleted of Treg cells but no control Abtreated mice developed disease, suggesting that genetic resistance to EAE in female
B10.S mice does not lie entirely in the Treg population. In female
B10.S mice, multiple factors may contribute to EAE resistance, i.e.,
Ag-specific defects in Th1 cytokine secretion and IL12-Rb2 expression (18, 19), a tendency to produce elevated amounts of Th2 cytokines (20), APCs (16) and the presence of a high proportion of

Treg cells that react with PLP 139–151 tetramers in their naive periphery (15). Once males develop EAE following anti-CD25 treatment, there were no other clinical differences between males and
females. Histologic disease in anti-CD25 Ab-treated male mice
was significantly greater than in the controls (p ≤ 0.0003) (Table I),
and there were more PMNs in CNS infiltrates (p ≤ 0.0004) (Table
I, Figure 1). The histologic disease in males was also more severe
than in anti-CD25-treated females (mean total inflammatory foci
= 124.9 vs 44.8) (p ≤ 0.05). The disease severity in females was enhanced when compared with control mice but inflammatory foci
contained fewer neutrophils (Table I, Figure 1b).
To determine the mechanisms for greater incidence and severity of EAE in Treg-depleted male B10.S mice, we tested whether
there are any differences in Treg cell function between male and
female B10.S mice in vitro.
We first determined that male B10.S mice have a higher percentage of CD3+ cells in their lymph nodes than age-matched female B10.S mice, but the percentage of Treg cells is lower in males
(Table II). We then confirmed that Treg cells in male and female
B10.S mice are equally effective in inhibiting expansion of effector cells using anti-CD3 as a stimulus (data not shown). FoxP3
mRNA, a marker for Treg cells, was also expressed in comparable
amounts (Figure 2a). Therefore, we could identify no major differences in Treg populations between male and female B10S mice.
We next tested whether Treg cells from male and female B10.S
mice have any defect in their suppressive function in response
to self-Ags using TCR tg mice specific to PLP 139– 151 (16). We
found that Treg cells from male and female tg B10.S mice did not
proliferate to PLP 139–151, whereas male and female effector cells
responded equally well to PLP 139– 151. Treg cells inhibited the
proliferative response of effector cells but there were differences;
the inhibition of CD4+CD25- cells mediated by Treg cells in female
B10.S mice was maintained even at low ratios of regulatory: effector cells. However, in male mice as ratios of Treg cells to effectors
were lowered, the effector cells expanded to a greater extent (Figure 2b). This suggests either that Treg cells from female mice are
more efficient in their suppressive function than those in males or
that the effector cells in males are capable of responding to autoantigens more vigorously than those in females. We quantified
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Figure 4. Ag-specific,
CD4+CD25- effector cells
from male B10.S mice expand more vigorously than
those derived from female
mice. a, CD4+CD25- cells isolated by magnetic separation from male and female
B10.S mice were stimulated
with anti-CD3 Ab (1 μg/ml)
and CD11+c cells as APCs,
and proliferation was measured as described in Materials and Methods. A representative experiment of three is
shown. b, CD3+ cells were
enriched from male and female B10.S mice pretreated
with anti-CD25 or IgG Ab
and immunized with PLP
139–151. The cells were
stimulated with PLP 139–
151 and proliferation was
measured as above. Mean
± SEM values are shown. (n
= males, 8; females, 7). (1.5
μg/ml, p ≤ 0.08; 15 μg/ml,
p ≤ 0.09).

the precursor frequency of PLP 139–151 tetramer+ cells in male

Figure 3. Depletion of Treg cells before immunization with PLP 139–
151 enhances Ag-specific T cell proliferation and inflammatory cytokines in male B10.S mice. a, Male B10.S mice pretreated with antiCD25 or isotype control on day -5 and day -3 were immunized with
PLP 139–151. Ten days later, CD3+ cells were stimulated with PLP
139–151 and proliferation was measured as described in Materials and
Methods. A representative experiment is shown. b, Viable lymphoblasts harvested from the cultures stimulated with PLP 139–151 were
stained with PLP 139–151 or TMEV 70–86 tetramers. Mean ± SEM values are shown (n = day 4, 6; day 6, 10). ( *,p ≤ 0.02; **, p≤ 0.01). c, Cytokine ELISA: supernatants from cultures stimulated with PLP 139–
151 were examined for cytokine secretion by ELISA and compared
between groups (n = 8–12 mice/group) (IL-2, p ≤ 0.01; IL-10, p ≤ 0.02;
IFN-γ, p ≤ 0.006, and IL-17, p ≤ 0.08). Intracellular staining: viable lymphoblasts were harvested on day 4 from the cultures described above
and restimulated with anti-TCR β and anti-CD28 Ab for 4–6 h and
stained with anti-CD4 and 7-AAD. The frequency of cytokine-secreting cells was then determined by flow cytometry in the live (7-AAD-)
CD4+ subset. Each bar represents mean ± SEM values (n = rat IgG, 9;
n = anti-CD25, 10). (IL-2 and IL-10, p ≤ 0.01; IL-4, p ≤ 0.0005; IFN-≤, p ≤
0.02; IL-6, p ≤ 0.001; and IL-17, p ≤ 0.056).

mice to be 0.04% of CD4 cells (8 in 20,000). By contrast, the precursor frequency in female B10.S mice is 40 in 20,000 CD4 cells (15).
We did not observe any significant shift in PLP 139– 151 tetramer
reactivity in effector vs Treg cells, as previously reported in female
B10.S mice (15) (data not shown). Therefore, the higher incidence
and greater severity of EAE in male B10.S mice are unlikely to be
due to an increased frequency or function of PLP 139–151-specific
Treg cells.
We next compared T cell proliferation to PLP 139–151 between anti-CD25 and rat IgG-treated male mice. The PLP
139–151-specific responses, but not NASE responses, were significantly higher in the anti-CD25 Ab-treated than in the control group (Figure 3a). Consistent with this, percentages of PLP

139–151 tetramer+CD4 cells were increased by ~3-fold more in
the anti-CD25 Ab-treated males compared with controls (Figure
3b). This response was specific because there was negligible reactivity to TMEV 70–86 tetramers. These data suggest that the expansion of PLP 139–151-reactive cells in mice depleted of Treg
cells contributed to the more severe disease. This expansion appeared to have resulted from the loss of regulation mediated by
Treg cells, which can prevent the expansion of effector cells in an
Ag nonspecific manner (21).
Previously, male SJL mice immunized with myelin basic protein or PLP were found to produce IL-4 and IL-10, while females
produced more IFN-γ (2, 22). We tested whether a similar bias
exists in immunized male B10.S mice, with or without Treg cell
depletion. By ELISA, the production of both IL-2 (p ≤ 0.01) and
IFN-γ (p ≤ 0.006) was significantly elevated, with a marginal increase in IL-17 production (p ≤ 0.08) on day 2 in the cultures derived from CD25+ cell-depleted male mice compared with controls (Figure 3c). As previously noted in female B10.S mice (15),
IL-10 secretion was reduced in the anti-CD25 Ab-treated group
(p ≤ 0.02), suggesting that Treg cells may directly or indirectly
regulate IL-10 production. However, by intracellular staining, the frequencies of cells secreting all of the cytokines tested
(IL-2, IL-4, IL-6, IL-10, IL-17, and IFN-γ) were elevated in antiCD25-treated male mice (Figure 3c). Among proinflammatory
cytokines, IFN-γ-secreting cells were present at a higher frequency (3.09 vs 1.35) followed by IL-17 (1.09 vs 0.41) and IL-6
(0.5 vs 0.21) in the anti-CD25-treated vs control mice. The number of TNF-α-secreting cells did not vary between groups (data
not shown). Recently, it was reported that IL-23-dependent
production of inflammatory cytokines (IL-17, IL-17F, IL-6, and
TNF-α) is essential for the development of CNS inflammation
(23). In anti-CD25 Ab-treated mice, the numbers of cells that secrete IFN-γ, IL-6, and IL-17 was increased, implying that Treg
cells regulate the expression of these cytokines. In the absence
of Treg cells, the effector cells producing inflammatory cytokines
may expand resulting in altered chemokines and increased proportions of PMNs in inflammatory foci (24).
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We then sought to detect any fundamental difference in the
expansion of effector cells between male and female B10.S wt
mice. Using anti-CD3 as a stimulus, we observed that the effector cells from male B10.S mice expanded to a greater extent than
those from female mice (Figure 4a). To verify that a similar differential response occurs to PLP 139–151, we immunized groups of
male and female B10.S mice with PLP 139–151 after treating them
with anti-CD25 or control Ab. We measured the PLP 139–151-specific response by [3H]thymidine incorporation. As expected, mice
depleted of CD25+ cells responded to PLP 139–151 significantly
more strongly than controls of either sex (Figure 4b). However,
the T cell response to PLP 139– 151 in the male B10.S mice tended
to be higher than in the female mice treated with anti-CD25 Ab,
especially at lower Ag concentrations (Figure 4b). Similar trends
were confirmed by using 5B6 tg T cells specific to PLP 139–151
(data not shown). These data suggest that the autoreactive effector
cells in male B10.S mice can respond to autoantigens vigorously,
but they are kept in check by Treg cells.
In summary, in male B10.S mice treated with anti-CD25 Ab,
the incidence of PLP 139–151-induced EAE was enhanced significantly when compared with female B10.S mice, suggesting that
Treg cells do not play as large of a role in mediating genetic resistance to EAE in female compared with male mice. Although there
was no fundamental difference in Treg cell function between male
and female mice, the effector cells from male B10.S mice in the absence of Treg cells tended to proliferate to a higher degree than
those from females. This suggests that male Treg cells control the
expansion of pathogenic autoreactive cells more effectively and
that this contributes to their greater disease resistance.
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